Fluxion Biosciences was formed in 2005 to address critical needs for cellular
analysis tools in the pharmaceutical, biotech and research industries. The company
has developed a proprietary microfluidic platform which enables precise cellular
manipulation, rapid low-volume compound addition, environmental control and
software-based data acquisition.
Fluxion's goal is to create innovative solutions for its customers which offer
superior performance, simplified workflows and cost savings over conventional
assay techniques. Fluxion's customers include:
Fluxion Debuts BioFlux Quattro High Throughput Array System for Live Cell Analysis
Microfluidic Design Enables High-Throughput Anti-Microbial Screening
Fluxion Biosciences Receives $200K Grant from National Cancer Institute
In this interview, we speak with Stanford's Gu Group about their newly developed metal nanocluster-based material that's advancing nanoscale 3D printing.
Professor Andre Nel
In this interview, AZoNano speaks with Professor Andre Nel about his involvement in innovative research describing the development of a 'glass bubble' nanocarrier that could help drug formulations access pancreatic cancer cells.
Jingang Li, Ph.D.
In this interview, AZoNano speaks with Jingang Li from the University of California, Berkley, who offers an introduction to the Nobel Prize-winning technology, Optical Tweezers.
The MiniCapt® Pro is a remote microbial air sampler that is ideal for the pharmaceutical manufacturing industry.
This product profile outlines the NanoRacer High-Speed AFM from Bruker JPK.
NMR spectroscopy is a characterization technique that is extensively used by chemical researchers.